
Radiologic Analysis of COVID-19 Infection
In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical, presented an integrated, comprehensive analysis using…
GoTo
In a recent webcast, Dr. Ronald Korn, Founder and CMO at Imaging Endpoints and Kelie Williams Luby, VP Clinical Trials Software at Mint Medical, presented an integrated, comprehensive analysis using…
GoTo
Next to clinical examination and endoscopy, cross-sectional imaging plays an important role in the diagnosis of head and neck tumors. Moreover, the choice of therapy is guided by the radiological…
GoTo
A recent prospective study [1] conducted by researchers at Cincinnati Children’s Hospital Medical Center compared manual 2D, semi-automated 2D, and volumetric measurement strategies for tumor…
GoTo
Dr. Nils Grosse Hokamp shares his experience of using mint Lesion™ at the University Hospital Cologne in this brief interview. He talks about how they have expanded their usage of mint Lesion™ over…
GoTo
Dr. Robert McFarland shares his experience of using mint Lesion™ at his radiology practice in this brief interview. He talks about the challenges of performing a PI-RADS assessment, how his workflow…
GoTo
A recent retrospective study [1] conducted by researchers at University Hospital Tuebingen focused on identifying imaging and clinical predictors of overall survival and treatment response in…
GoTo
Prof. Dr. Hans-Christoph Becker from Stanford University, a long-standing user of mint Lesion™, shares his experience of using the software in this brief interview. He talks about the reaction he…
GoTo
In a retrospective study [1], a team from Royal Marsden in London and Sutton explored changes of CT texture analysis metrics in unresectable liver metastases in patients with colorectal cancer (CRC)…
GoTo
From my initial experience with mint Lesion™ software, and over the time I have been using it, I have been pleased with the software and come to depend on it. Assessing tumor response to therapy…
GoTo
Funded by the National Institute of Health Research (NIHR) and sponsored by the Imperial College London, the MROC study boasts impressive figures: 645 women with suspected or confirmed ovarian cancer…
GoTo